Clinical Trials Logo

Filter by:
NCT ID: NCT01609140 Completed - Clinical trials for Coronary Heart Disease

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Start date: May 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and cholesterol lowering effects of MPSK3169A when given as subcutaneous (SC) injections over a 24-week period to patients with a high risk of cardiovascular events and LDL-c levels well above goal.

NCT ID: NCT01608880 Completed - Clinical trials for Mastectomy Flap Necrosis

Effect of Nitroglycerin Ointment on Mastectomy Flap Necrosis

Start date: August 2012
Phase: N/A
Study type: Interventional

Background: Mastectomy flap necrosis (MFN) is a common complication that affects recovery, reconstructive success and aesthetic outcome. Nitroglycerin (NTG) ointment is a potent topical vasodilator that increases local blood flow by dilating arteries and veins without altering the ratio of pre- to post-capillary resistance. There are no studies that evaluate whether the application of NTG ointment in patients undergoing Skin-sparing mastectomy (SSM) or nipple-sparing mastectomy (NSM) and immediate reconstruction decreases the rate of mastectomy flap necrosis. Objective: To evaluate if the post-operative application of NTG ointment improve rates of MFN in patients undergoing SSM or NSM with immediate breast reconstruction compared to patients receiving placebo. Hypothesis: In patients undergoing SSM and immediate breast reconstruction there will be a decrease in the rate of MFN in those who receive NTG ointment compared to those who receive placebo.

NCT ID: NCT01608763 Completed - Problem Drinking Clinical Trials

What is the Active Ingredient in Personalized Feedback Interventions for Problem Drinkers? A Randomized Controlled Trial

Start date: May 2012
Phase: N/A
Study type: Interventional

The major objective of this project is to conduct a randomized controlled trial comparing the impact of the normative feedback and other personalized feedback components of the Check Your Drinking (CYD) Internet-based intervention in the general population. Eligible problem drinking participants will be randomly assigned to one of four conditions in a 2 by 2 design - to receive just the normative feedback component of the CYD intervention, just the other personalized feedback information, to a no intervention control condition, or to receive the full CYD intervention. The no intervention control condition will not be sent any intervention materials but will instead be sent a list of the different components of the CYD feedback and will be asked to think about how useful they would find each of them. All participants will be followed-up at 3 months.

NCT ID: NCT01608711 Completed - Pancreatic Cancer Clinical Trials

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Start date: August 7, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to continue the safety and immunogenicity of AGS-1C4D4 administered in combination with gemcitabine in subjects previously treated in protocol 2008002.

NCT ID: NCT01608672 Completed - Glabellar Lines Clinical Trials

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Start date: April 1, 2012
Phase:
Study type: Observational

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

NCT ID: NCT01608061 Completed - Alzheimer Disease Clinical Trials

ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease

ADvance
Start date: May 2012
Phase: N/A
Study type: Interventional

The primary objective of this feasibility study is to evaluate the safety of DBS-f in patients with mild Alzheimer's disease by assessing all device and/or therapy related adverse events. The secondary objective is to preliminarily estimate the treatment effect size on the outcomes of interest at 12 months post-randomization. The objectives do not involve formal tests of hypotheses.

NCT ID: NCT01608035 Completed - Chronic Pain Clinical Trials

Sciatic Perineural Versus Stump Catheter for Below Knee Amputation

Start date: September 2012
Phase: Phase 0
Study type: Interventional

The goal of this study is to determine if pre-operative placement of the continuous peripheral nerve block by an anesthesiologist using ultrasound technology is more effective than a continuous peripheral nerve block placed during the surgery by a surgeon for patients undergoing a limb amputation

NCT ID: NCT01607905 Completed - Solid Tumor Clinical Trials

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Start date: June 18, 2012
Phase: Phase 1
Study type: Interventional

Phase 1 study to evaluate the safety and tolerability of selinexor and determine the Recommended Phase 2 Dose (RP2D) of selinexor for advanced or metastatic solid tumor malignancies.

NCT ID: NCT01607892 Completed - Clinical trials for Hematological Malignancies

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Start date: July 23, 2012
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to find out more information relating to the highest dose of KCP-330 that can be given safely and side effects it may cause, to examine how the body affects KCP-330 concentrations in the blood (pharmacokinetics or PK), to examine the effects of KCP-330 on the body (pharmacodynamics or PDn) and to obtain information on its effectiveness in treating cancer.

NCT ID: NCT01607658 Completed - Clinical trials for Female Orgasmic Disorder

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Start date: May 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess and compare the effects of 3 dose strengths of TBS-2 intranasal testosterone gel to placebo on the occurrence of orgasm.